Evidence that nicotinic alpha(7) receptors are not involved in the hyperlocomotor and rewarding effects of nicotine

Citation
Aj. Grottick et al., Evidence that nicotinic alpha(7) receptors are not involved in the hyperlocomotor and rewarding effects of nicotine, J PHARM EXP, 294(3), 2000, pp. 1112-1119
Citations number
45
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
ISSN journal
00223565 → ACNP
Volume
294
Issue
3
Year of publication
2000
Pages
1112 - 1119
Database
ISI
SICI code
0022-3565(200009)294:3<1112:ETNARA>2.0.ZU;2-R
Abstract
Neuronal nicotinic receptors are comprised of combinations of alpha(2-8) an d beta(2-4) subunits arranged to form a pentameric receptor. Currently, the principal central nervous system (CNS) subtypes are believed to be alpha(4 )beta(2) and a homomeric alpha(7) receptor, although other combinations alm ost certainly exist. The identity of the nicotinic receptor subtype(s) invo lved in the rewarding effects of nicotine are unknown. In the present study , using some recently described subtype selective nicotinic agonists and an tagonists, we investigated the role of the alpha(7) nicotinic receptor in t he mediation of nicotine-induced hyperactivity and self-administration in r ats. The alpha(7) receptor agonists AR-R 17779 and DMAC failed to stimulate locomotor activity in both nicotine-nontolerant and -sensitized rats. In c ontrast, nicotine and the putative alpha(4)beta(2) subtype selective agonis t SIB1765F increased activity in both experimental conditions. In nicotine- sensitized rats, the high affinity (including the alpha(4)beta(2) subtype) nicotinic antagonist dihydro-beta-erythroidine (DH beta E), but not the sel ective alpha(7) antagonist methyllycaconitine (MLA), antagonized a nicotine -induced hyperactivity. Similarly, DH beta E, but not MLA, pretreatment red uced nicotine self-administration. Electrophysiology experiments using Xeno pus oocytes expressing the human alpha(7) receptor confirmed AR-R 17779 and DMAC to be potent agonists at this site, and further studies demonstrated the ability of systemically administered AR-R 17779 to penetrate into the C NS. Taken together, these results indicate a negligible role of alpha(7) re ceptors in nicotine-induced hyperlocomotion and reward in the rat, and supp ort the view for an involvement of a member from the high-affinity nicotini c receptor subclass, possibly alpha(4)beta(2). Issues such as drug potency, CNS penetration, and desensitization of the alpha(7) receptor are discusse d.